Christian Rommel

Insider Reports History

Location
C/O Crispr Therapeutics, 105 West First Street, Boston, MA
Signature
/s/ Elizabeth Ryland Waldinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christian Rommel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13K Jun 5, 2025 Direct

Insider Reports Filed by Christian Rommel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Jun 5, 2025 1 $0 4 Jun 6, 2025 Director
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
CRSP CRISPR Therapeutics AG May 30, 2024 0 $0 3 May 30, 2024 Director